Welltower, a real estate investment trust, has revealed a massive UK deal focusing on long-term care. This includes the acquisition of the Barchester Healthcare Portfolio. This move follows a six-year negotiation and further expands Welltower's UK footprint.
UBS maintains a buy recommendation for Welltower, signifying belief in the company's positive future. Even as the company's profit margin miss poses a challenge to the bullish growth narrative, strong forecasts persist. Various analysts offer insights, among them Evercore ISI keeping their Hold Rating on Welltower, revealing mixed opinions across the board.
Several financial institutions including Keybank National Association OH and Strs Ohio have sold their shares in Welltower. However, others like Simon Quick Advisors LLC and Envestnet Asset Management Inc. have increased their positions.
The company recently announced major transactions totalling £23bn, shifting focus to senior housing. In addition to this, Welltower 3.0 initiative is being launched, signifying a new phase in the company’s growth. Nonetheless, Q3 results show a dip in stocks despite revenue beat, and the company has reduced its guidance.
Cantor Fitzgerald has raised its price target for Welltower and maintains an overweight rating while UBS also maintains a buy rating and raises its target price to $203.
Welltower WELL News Analytics from Thu, 15 May 2025 07:00:00 GMT to Sat, 01 Nov 2025 09:11:01 GMT - Rating 5 - Innovation -1 - Information 4 - Rumor -3
